Stock Events

Stock Events

ElectroCore 

$10.66
64
+$0.39+3.8% 14:01 Today

Statistics

Day High
10.66
Day Low
9.85
52W High
10.68
52W Low
4.41
Volume
5,241
Avg. Volume
119,514
Mkt Cap
96.11M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.61
-0.49
-0.37
-0.26
Expected EPS
-0.256
Actual EPS
N/A

Financials

-43.6%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
32.03MRevenue
-13.97MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ECOR. It's not an investment recommendation.
Apple
12
AAPL
Tesla
12
TSLA
Microsoft
11
MSFT
Amazon
11
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
LivaNova
LIVN
Mkt Cap4.53B
LivaNova PLC operates in the same space of neuromodulation, providing therapies that could directly compete with ElectroCore's solutions for epilepsy and other neurological conditions.
Inspire Medical Systems
INSP
Mkt Cap1.65B
Inspire Medical Systems, Inc. offers innovative obstructive sleep apnea treatments using nerve stimulation, a direct competitor to ElectroCore's nerve stimulation therapies.
Neogen
NEOG
Mkt Cap2.54B
Neogen Corporation, while primarily focused on food and animal safety, has divisions that explore bioelectronic medicine, potentially overlapping with ElectroCore's market.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation offers a wide range of medical devices, including neuromodulation products that could serve as alternatives to ElectroCore's technology.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie Inc., through its acquisition of Allergan, has entered the neuromodulation market, potentially competing with ElectroCore's offerings.
Medtronic
MDT
Mkt Cap116.83B
Medtronic PLC provides a broad array of medical devices, including those for neuromodulation, directly competing with ElectroCore's nerve stimulation devices.
Smith & Nephew
SNN
Mkt Cap12.48B
Smith & Nephew plc, while mainly focused on orthopedics, has started exploring the bioelectronic medicine space, which could put it in competition with ElectroCore.
Stryker
SYK
Mkt Cap130.11B
Stryker Corporation's medical technologies, including neurotechnology and spine products, could indirectly compete with ElectroCore by offering different solutions for similar conditions.

About

electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
Show more...
CEO
Thomas J. Errico
Employees
83
Country
United States
ISIN
US28531P2020
WKN
000A3D3BQ

Listings

STU
DE
43E0.STU
XNAS
US
ECOR
STU
DE
43E.STU
MU
DE
43E0.MU

0 Comments

Share your thoughts

FAQ

What is ElectroCore stock price today?▼
The current price of ECOR is $10.66 USD — it has increased by +3.8% in the past 24 hours. Watch ElectroCore stock price performance more closely on the chart.
What is ElectroCore stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange ElectroCore stocks are traded under the ticker ECOR.
Is ElectroCore stock price growing?▼
ECOR stock has risen by +10.11% compared to the previous week, the month change is a +76.02% rise, over the last year ElectroCore has showed a +108.25% increase.
What is ElectroCore market cap?▼
Today ElectroCore has the market capitalization of 96.11M
When is the next ElectroCore earnings date?▼
ElectroCore is going to release the next earnings report on October 29, 2026.
What were ElectroCore earnings last quarter?▼
ECOR earnings for the last quarter are -0.33 USD per share, whereas the estimation was -0.42 USD resulting in a +21.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is ElectroCore revenue for the last year?▼
ElectroCore revenue for the last year amounts to 32.03M USD.
What is ElectroCore net income for the last year?▼
ECOR net income for the last year is -13.97M USD.
How many employees does ElectroCore have?▼
As of August 19, 2026, the company has 83 employees.
In which sector is ElectroCore located?▼
ElectroCore operates in the Health & Wellness sector.
When did ElectroCore complete a stock split?▼
The last stock split for ElectroCore was on February 15, 2023 with a ratio of 1:15.
Where is ElectroCore headquartered?▼
ElectroCore is headquartered in ROCKAWAY, United States.